{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:39:21Z","timestamp":1779082761547,"version":"3.51.4"},"reference-count":23,"publisher":"The Journal of Rheumatology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The diagnosis in the studies analyzing HLA of dermatomyositis (DM) was based on a combined clinical category of polymyositis\/DM. This retrospective study investigated the associations of HLA with 5 DM-specific autoantibodies in Japanese patients diagnosed by muscle pathology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We diagnosed Japanese patients with DM based on sarcoplasmic expression of myxovirus resistance protein A. These patients underwent investigation for 5 DM-specific autoantibodies and HLA genotyping.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 175 patients (83 males and 92 females; range 1-86 yrs; mean 46 yrs), 173 (98.9%) had 1 of the 5 autoantibodies. Seven alleles\u2014<jats:italic>A*02:07, B*46:01, DRB1*04:07, DRB1*07:01, DRB1*08:03, DQB1*06:01<\/jats:italic>, and<jats:italic>DPB1*02:02<\/jats:italic>\u2014were more frequently detected in the patients with DM than healthy controls, but these associations were not significant after multiple testing correction. Stratifying by DM-specific autoantibodies, we found the associations of 6 already known and 7 new alleles\u2014<jats:italic>B*48:01, B*52:01, C*12:02, DRB1*04:05, DRB1*15:02, DPB1*05:01<\/jats:italic>, and<jats:italic>DPB1*09:01<\/jats:italic>\u2014with subsets of DM. Moreover, significant associations of 5 alleles with antinucleosome remodeling deacetylase complex (Mi-2) remained after multiple testing correction. In particular, the<jats:italic>DRB1*04:07<\/jats:italic>(odds ratio [OR 28.9]; corrected<jats:italic>P<\/jats:italic>= 2.7 \u00d7 10<jats:sup>\u22126<\/jats:sup>) and<jats:italic>DQB1*06:01<\/jats:italic>(OR 4.0; corrected<jats:italic>P<\/jats:italic>= 1.6 \u00d7 10<jats:sup>\u22124<\/jats:sup>) alleles were significantly more prevalent in patients with anti-Mi-2 antibody than in controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study demonstrates DM-specific autoantibodies defined immunogenetic subsets of DM.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.2022-1321","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T12:20:14Z","timestamp":1686831614000},"page":"1159-1164","source":"Crossref","is-referenced-by-count":7,"title":["Association Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A"],"prefix":"10.3899","volume":"50","author":[{"given":"Munenori","family":"Oyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Ohnuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Uruha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Nishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4388-4574","authenticated-orcid":false,"given":"Shingo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jantima","family":"Tanboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Okiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"2023090107351018000_50.9.1159.1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ncn3.12563","article-title":"Autoimmune myositis\u2013Mechanism and therapy development","volume":"10","author":"Uruha","year":"2022","journal-title":"Neurol Clin Neurosci"},{"key":"2023090107351018000_50.9.1159.2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11926-014-0465-0","article-title":"Amyopathic dermatomyositis: definitions, diagnosis, and management","volume":"16","author":"Bailey","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"2023090107351018000_50.9.1159.3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaneurol.2020.0673","article-title":"Association of dermatomyositis sine dermatitis with anti-nuclear matrix protein 2 autoantibodies","volume":"77","author":"Inoue","year":"2020","journal-title":"JAMA Neurol"},{"key":"2023090107351018000_50.9.1159.4","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/rheumatology\/keab518","article-title":"Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash","volume":"61","author":"Ichimura","year":"2022","journal-title":"Rheumatology"},{"key":"2023090107351018000_50.9.1159.5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120682"},{"key":"2023090107351018000_50.9.1159.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.10.005"},{"key":"2023090107351018000_50.9.1159.7","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2015.28"},{"key":"2023090107351018000_50.9.1159.8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/14397595.2019.1637593","article-title":"Human leukocyte antigen in Japanese patients with idiopathic inflammatory myopathy","volume":"30","author":"Furukawa","year":"2020","journal-title":"Mod Rheumatol"},{"key":"2023090107351018000_50.9.1159.9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215046"},{"key":"2023090107351018000_50.9.1159.10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semarthrit.2019.03.005","article-title":"Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients","volume":"49","author":"Kang","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2023090107351018000_50.9.1159.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.22164"},{"key":"2023090107351018000_50.9.1159.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.34657"},{"key":"2023090107351018000_50.9.1159.13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170165"},{"key":"2023090107351018000_50.9.1159.14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003568"},{"key":"2023090107351018000_50.9.1159.15","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12519"},{"key":"2023090107351018000_50.9.1159.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"2023090107351018000_50.9.1159.17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000416"},{"key":"2023090107351018000_50.9.1159.18","unstructured":"The R Project for Statistical Computing. [Internet. Accessed March 20, 2023.] Available from: https:\/\/www.r-project.org"},{"key":"2023090107351018000_50.9.1159.19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.8.732"},{"key":"2023090107351018000_50.9.1159.20","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20464"},{"key":"2023090107351018000_50.9.1159.21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21805"},{"key":"2023090107351018000_50.9.1159.22","unstructured":"HLA Laboratory. [Internet. Accessed March 20, 2023.] Available from: https:\/\/hla.or.jp\/med\/frequency_search\/en\/haplo\/search\/RQ\/"},{"key":"2023090107351018000_50.9.1159.23","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/kex188","article-title":"Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody-positive inflammatory myositis","volume":"56","author":"Abe","year":"2017","journal-title":"Rheumatology"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2022-1321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T14:36:49Z","timestamp":1693579009000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2022-1321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,1]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.3899\/jrheum.2022-1321"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2022-1321","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}